Mauna Kea Technologies S.A.
PAR: ALMKT.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Alexandre Loiseau
- Employees
- 65
- Headquarters
- Paris, France
- IPO year
- 2023
- Market cap
- €14.5M
- Website
- https://www.maunakeatech.com
Loading ALMKT…
Loading profile data…Frequently asked questions about ALMKT
What does Mauna Kea Technologies S.A. (ALMKT.PA) do?
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression...
Where does ALMKT.PA trade?
Mauna Kea Technologies S.A. (ALMKT.PA) trades on the Euronext Paris.
What sector is ALMKT.PA in?
Mauna Kea Technologies S.A. (ALMKT.PA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Mauna Kea Technologies S.A.?
Alexandre Loiseau is the chief executive officer of Mauna Kea Technologies S.A. (ALMKT.PA).
Where is Mauna Kea Technologies S.A. headquartered?
Mauna Kea Technologies S.A. is headquartered in France.
Does ALMKT.PA pay a dividend?
Mauna Kea Technologies S.A. (ALMKT.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALMKT.PA go public?
Mauna Kea Technologies S.A. (ALMKT.PA) completed its initial public offering in 2023.